Location: Hellerup, Denmark
CIK: 0001388325 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $1.288B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BN | BROOKFIELD CORP | 3,496,245 | $160M | 12.5% | $29.96 | +52.0% | CL A LTD VT SH | 11271J107 |
| EWTX | EDGEWISE THERAPEUTICS INC | 5,350,000 | $133M | 10.3% | $18.02 | +11.4% | COM | 28036F105 |
| ASML | ASML HOLDING N V | 113,946 | $122M | 9.5% | $662.32 | — | N Y REGISTRY SHS | N07059210 |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,264,028 | $99.85M | 7.8% | $12.27 | +485.2% | COM | 604749101 |
| CRM | SALESFORCE INC | 330,187 | $87.47M | 6.8% | $205.72 | +20.6% | COM | 79466L302 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,625,000 | $75.64M | 5.9% | $25.38 | +75.4% | COM | 22663K107 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,380,000 | $74.07M | 5.8% | $16.63 | +64.9% | COM | 92790C104 |
| MPLT | MAPLIGHT THERAPEUTICS INC | 3,686,622 | $64.76M | 5.0% | $16.75 | 0.0% | COM | 56565P103 |
| ZBIO | ZENAS BIOPHARMA INC | 1,450,000 | $52.65M | 4.1% | $14.60 | +125.3% | COM | 98937L105 |
| PHVS | PHARVARIS N V | 1,750,000 | $48.56M | 3.8% | $15.36 | +56.8% | COM | N69605108 |
| APGE | APOGEE THERAPEUTICS INC | 570,000 | $43.02M | 3.3% | $41.12 | +53.2% | COM | 03770N101 |
| PCVX | VAXCYTE INC | 916,160 | $42.27M | 3.3% | $39.88 | +12.1% | COM | 92243G108 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 660,000 | $39.22M | 3.0% | $77.70 | -29.9% | COM | 09061G101 |
| AVBP | ARRIVENT BIOPHARMA INC | 1,942,142 | $39.08M | 3.0% | $20.49 | +1.6% | COM | 04272N102 |
| BABA | ALIBABA GROUP HLDG LTD | 257,327 | $37.72M | 2.9% | $165.09 | — | SPONSORED ADS | 01609W102 |
| INSM | INSMED INC | 200,000 | $34.81M | 2.7% | $23.10 | +689.9% | COM PAR $.01 | 457669307 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 1,200,000 | $32.59M | 2.5% | $34.88 | -24.5% | COM NEW | 15117B202 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 3,650,737 | $27.38M | 2.1% | $12.43 | -18.4% | COM | 35104E100 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 1,961,317 | $24.56M | 1.9% | $11.58 | — | COM NEW | 107924102 |
| ELVN | ENLIVEN THERAPEUTICS INC | 1,480,000 | $22.79M | 1.8% | $19.25 | +3.5% | COM | 29337E102 |
| VALN | VALNEVA SE | 2,305,000 | $20.33M | 1.6% | $5.67 | — | SPONSORED ADS | 92025Y103 |
| LNZA | LANZATECH GLOBAL INC | 158,148 | $2.176M | 0.2% | $28.70 | -34.8% | COM NEW | 51655R200 |
| MQ | MARQETA INC | 441,558 | $2.097M | 0.2% | $22.37 | -78.5% | CLASS A COM | 57142B104 |
| IOBT | IO BIOTECH INC | 2,512,453 | $1.53M | 0.1% | $6.26 | -88.1% | COM | 449778109 |